Related Experiment Video
Updated: May 12, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
The role of the mTOR pathway during liver regeneration and tumorigenesis
Ganna Panasyuk1, Cecilia Patitucci, Catherine Espeillac
1Inserm U845, Paris Descartes University, 96, rue Didot, 75014 Paris, France.
Abstract:
It is established that overnutrition is a risk factor for hepatocellular carcinoma. Il has been proposed that hepatic steatosis leads to a subinflammatory response and to the production of mitogenic cytokines. Our team is focused on the role of mammalian Target of Rapamycin (mTOR) in two pathophysiological conditions that modulate liver growth: liver regeneration after partial hepatectomy, and steatosis-associated tumorigenesis. Target kinases of mTOR seem more specifically involved in these processes: while S6K1 contributes to liver regeneration following hepatectomy, Akt2 is implicated in steatosis-associated tumorigenesis. In addition, recent data indicate that the transcription factor PPARγ, through an activation of glycolytic enzymes, could promote liver steatosis, hypertrophy and hyperplasia.
Insights
Overnutrition drives liver cancer risk. This study reveals mammalian Target of Rapamycin (mTOR) pathway kinases, Akt2 and S6K1, play distinct roles in liver regeneration and steatosis-associated tumorigenesis.
Area of Science:
- Hepatocellular carcinoma research
- Molecular mechanisms of liver disease
- Cellular signaling pathways
Background:
- Overnutrition is a known risk factor for hepatocellular carcinoma (HCC).
- Hepatic steatosis (fatty liver) may promote a pro-tumorigenic environment through inflammation and mitogenic cytokines.
- The mammalian Target of Rapamycin (mTOR) pathway is crucial for regulating cell growth and metabolism.
Purpose of the Study:
- To investigate the role of mTOR signaling in liver regeneration after partial hepatectomy.
- To elucidate the involvement of mTOR in steatosis-associated liver tumorigenesis.
- To identify specific mTOR kinases mediating these distinct liver processes.
Main Methods:
- Investigated liver regeneration models.
- Analyzed steatosis-associated liver tumorigenesis.
- Focused on the activity of mTOR pathway kinases, including S6K1 and Akt2.
- Examined the role of transcription factor PPARγ in promoting liver steatosis and growth.
Main Results:
- S6K1 kinase is implicated in promoting liver regeneration post-hepatectomy.
- Akt2 kinase is specifically involved in steatosis-associated liver tumorigenesis.
- PPARγ activation may drive liver steatosis, hypertrophy, and hyperplasia via glycolytic enzyme activation.
Conclusions:
- mTOR pathway kinases exhibit distinct roles in liver growth regulation and tumorigenesis.
- Targeting specific mTOR kinases may offer therapeutic strategies for liver diseases.
- Understanding the interplay between metabolic factors (steatosis, PPARγ) and mTOR is critical for HCC prevention.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

